Total | n | % |
---|---|---|
183 | ||
Age (years) at disease manifestation | ||
 Median (IQR) | 56 (44–65) | |
 < 40 | 14 | 7.7 |
 40–49 | 19 | 10.4 |
 50–59 | 21 | 11.5 |
 60–69 | 23 | 12.6 |
 70–79 | 11 | 6.0 |
 ≥ 80 | 2 | 1.0 |
 Unknown | 93 | 50.8 |
Sex | ||
 Male | 75 | 41.0 |
 Female | 108 | 59.0 |
Tumor site | ||
 Colon and rectum | 34 | 18.6 |
 Pancreatic | 24 | 13.1 |
 Lung | 18 | 9.8 |
 Ovary/fallopian tube | 16 | 8.7 |
 Breast | 15 | 8.2 |
 Stomach | 11 | 6.0 |
 Cervix | 8 | 4.4 |
 Other, including unknown primary | 8 | 4.4 |
 Skin/melanoma | 8 | 4.4 |
 Soft tissue | 7 | 3.8 |
 Biliary | 6 | 3.3 |
 Head and neck | 5 | 2.7 |
 CNS/brain | 4 | 2.2 |
 Bladder/urinary | 3 | 1.6 |
 Uterus | 3 | 1.6 |
 Kidney | 3 | 1.6 |
 Bone | 2 | 1.1 |
 Small bowel | 2 | 1.1 |
 Prostate | 2 | 1.1 |
 Ampulla of Vater | 1 | 0.5 |
 Pleura | 1 | 0.5 |
 Testis | 1 | 0.5 |
 Liver | 1 | 0.5 |
Stage | ||
 I | 7 | 3.8 |
 II | 15 | 8.2 |
 III | 12 | 6.6 |
 IV | 26 | 14.2 |
 Not allowed to collect/not reported/unknown | 123 | 67.2 |
Metastasis stage | ||
 M0 | 65 | 35.5 |
 M1 | 46 | 25.1 |
 Not allowed to collect/not reported/MX/Unknown | 72 | 39.3 |